Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
D000042:Absorption; D000284:Administration, Oral; D000336:Aerosols; D000420:Albuterol / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents; D002396:Catechols / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D006207:Half-Life; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000627:therapeutic use; D007700:Kinetics; D009119:Muscle Contraction / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009928:Organ Specificity; D010880:Piperidines / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D013726:Terbutaline / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced
D000336:Aerosols; D001993:Bronchodilator Agents; D002396:Catechols; D010880:Piperidines; C084590:rimiterol; D007545:Isoproterenol; D013726:Terbutaline; D000420:Albuterol